<DOC>
	<DOCNO>NCT01204502</DOCNO>
	<brief_summary>Bone marrow blood stem cell transplantation use treat wide range life-threatening condition . T lymphocytes carry graft powerful beneficial effect play vital role eradication leukaemia fight infection , also damage healthy tissue cause graft-versus-host disease ( GVHD ) . To safeguard GVHD , investigator propose modify T cell encode 'switch ' eliminate problem arise . Children receive half-matched ( haploidentical ) transplant parent likely benefit strategy . At present patient receive blood stem cell parent , T cell remove risk serious GVHD unacceptable . This mean much likely suffer life threatening infection experience relapse leukaemia . The investigator want use gene therapy produce `` safe '' T cell use strengthen transplant prevent serious complication .</brief_summary>
	<brief_title>Suicide Gene Therapy Trial</brief_title>
	<detailed_description />
	<mesh_term>Suicide</mesh_term>
	<criteria>1 . Patients primary immunodeficiency , haematological malignancy metabolic disorder GOSH ( child sex , age 0 16 year ) undergo haploidentical transplant 2 . Both patient donor must give informed consent writing . 3 . The donor must willing , able available donation T cell collection whole blood leukapheresis . 4 . The patient free serious intercurrent illness . 1 . Donor unfit unavailable 2 . Donor positive Hepatitis B C , HTLV1 , HIV 3 . Patient receive Ganciclovir , Aciclovir , Cidofovir result active CMV , adenovirus , varicella zoster herpes simplex infection infection 4 . GVHD â‰¥ grade II infusion gene modify T cell 5 . Serious intercurrent illness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Gene therapy</keyword>
	<keyword>Haploidentical</keyword>
	<keyword>Bone marrow transplant</keyword>
	<keyword>Graft versus host disease</keyword>
	<keyword>haploidentical stem cell transplantation</keyword>
	<keyword>T-cell suicide gene therapy</keyword>
</DOC>